Why a Triple-Ester Blend

Three nandrolone esters with different release rates, loaded into one vial:

• Stable serum levels. The short, medium, and long esters together flatten the peak‑to‑trough curve a single ester would produce.
• Fewer injections. Once‑weekly dosing covers the full therapeutic window. No daily or every‑other‑day schedule.
• Faster onset, longer tail. Phenylpropionate acts within 24–48 hours so you don’t wait two weeks for the compound to engage.
• One compound, three release curves. Replaces what would otherwise be three separate purchases and three separate inventory items.

Intended for use under the supervision of a qualified medical professional and in jurisdictions where lawful.

Administration

Doses must be individualized under the supervision of a qualified clinician based on baseline bloodwork, body weight, and ongoing lab monitoring.

Release Profile

Three esters, three different chain lengths, three different release rates — layered to deliver a smooth serum curve:

• Phenylpropionate — onset within 24–48 h, half‑life ~3 days. Gets the compound working fast.
• Isocaproate — medium chain, half‑life ~5–6 days. Bridges the gap between fast and slow esters.
• Decanoate — long chain, half‑life ~12–15 days. Holds the curve steady through the rest of the week.

Net effect: stable nandrolone serum levels with weekly administration — no peak‑and‑crash, no need for short‑ester top‑ups, no daily injections.

Storage

• Store at 15–25 °C, away from direct sunlight
• Keep the vial in its original carton until immediately before use
• Do not refrigerate — oil‑based suspensions thicken at low temperatures
• Discard any vial showing precipitation, discolouration, or a compromised flip‑cap seal

Contraindications & Cautions

• Not for use during pregnancy, lactation, or with known carcinoma of the breast or prostate
• Severe hepatic, renal, or cardiac impairment
• Hypersensitivity to nandrolone esters or to the oil carrier
• Concurrent anticoagulant therapy — monitor INR with your clinician

Regular bloodwork is advised (CBC, lipid panel, liver enzymes, hormone panel). Discontinue and seek medical advice if jaundice, abnormal liver function, or significant lipid changes appear.

Why a Long-Ester Testosterone

• Stable serum on weekly injections. Once or twice a week is enough — no daily injection schedule.
• The foundation compound. Almost every protocol fails without a proper test base. Enanthate is the standard.
• Predictable and well‑tolerated. Decades of clinical use mean the dose–response is well understood.
• Suitable for TRT and cycle use. Same compound, just different dose ranges.

Intended for use under the supervision of a qualified medical professional and in jurisdictions where lawful.

Administration

Doses must be individualized under the supervision of a qualified clinician based on baseline bloodwork and ongoing monitoring.

Release Profile

Enanthate is a 7‑carbon ester that hydrolyses gradually after intramuscular injection:

• Half-life — approximately 7 days
• Onset — 5–7 days for serum to climb above baseline
• Plateau — stable steady‑state by week 4–6 of consistent dosing
• Clearance — serum drops over 2–3 weeks after the final injection

Storage

• Store at 15–25 °C, away from direct sunlight
• Keep in the original carton until immediately before use
• Do not refrigerate — the oil suspension thickens at low temperatures
• Discard any vial with precipitation, discolouration, or a compromised cap seal

Contraindications & Cautions

• Not for use during pregnancy, lactation, or with known carcinoma of the breast or prostate
• Severe hepatic, renal, or cardiac impairment
• Hypersensitivity to testosterone esters or to the oil carrier
• Concurrent anticoagulant therapy — monitor INR

Regular bloodwork is advised (CBC, lipid panel, liver enzymes, hormone panel, hematocrit). Discontinue and seek medical advice if abnormal lab values appear.

Why a Short-Ester Testosterone

• Fast onset. Active within 24–48 hours — no two‑week wait for serum levels to climb.
• Tighter dose control. Short half-life means you can fine‑tune week to week instead of dosing blind.
• Easier to clear. If sides arise or you need to taper, propionate is out of your system in days.
• Less water retention than enanthate or cypionate at equivalent active dose.

Intended for use under the supervision of a qualified medical professional and in jurisdictions where lawful.

Administration

Doses must be individualized under the supervision of a qualified clinician based on baseline bloodwork and ongoing monitoring.

Release Profile

Propionate is the shortest commonly‑used testosterone ester:

• Half-life — approximately 2 days
• Onset — serum rises within 24–48 hours of injection
• Peak — serum noticeably elevated for 2–3 days after each shot
• Clearance — serum drops noticeably 3–4 days after the last injection

Storage

• Store at 15–25 °C, away from direct sunlight
• Keep in the original carton until immediately before use
• Do not refrigerate — the oil suspension thickens at low temperatures
• Discard any vial with precipitation, discolouration, or a compromised cap seal

Contraindications & Cautions

• Not for use during pregnancy, lactation, or with known carcinoma of the breast or prostate
• Severe hepatic, renal, or cardiac impairment
• Hypersensitivity to testosterone esters or to the oil carrier
• Some users find propionate causes more injection‑site irritation than longer esters

Regular bloodwork is advised. Discontinue and seek medical advice if abnormal lab values appear.

Why a Short-Ester Nandrolone

• Faster onset than decanoate. Active within days, not the 2–3 weeks long‑ester nandrolones take.
• Joint and connective tissue support. Nandrolone’s most well‑known practical benefit, preserved in this faster ester.
• Strong protein synthesis with less water retention than the long‑ester version.
• Easier to clear if sides develop or you need to taper out of a protocol.

Intended for use under the supervision of a qualified medical professional and in jurisdictions where lawful.

Administration

Doses must be individualized under the supervision of a qualified clinician based on baseline bloodwork and ongoing monitoring.

Release Profile

Phenylpropionate is the same short ester used in the “fast” component of Nandrolin Blend 250:

• Half-life — approximately 3 days
• Onset — within 24–48 hours of first injection
• Stable serum — within 7–10 days of consistent dosing
• Clearance — drops noticeably 4–5 days after the last injection

Storage

• Store at 15–25 °C, away from direct sunlight
• Keep in the original carton until immediately before use
• Do not refrigerate
• Discard any vial with precipitation, discolouration, or a compromised cap seal

Contraindications & Cautions

• Not for use during pregnancy, lactation, or with known carcinoma of the breast or prostate
• Severe hepatic, renal, or cardiac impairment
• Hypersensitivity to nandrolone esters or to the oil carrier
• Nandrolone strongly suppresses endogenous testosterone — run with a test base

Regular bloodwork is advised (CBC, lipid panel, prolactin, hormone panel). Discontinue and seek medical advice if abnormal lab values appear.

Why a DHT-Derivative Finisher

• Hardens muscle tissue. The cosmetic signature compound — tight, dry, visibly dense.
• Anti‑estrogenic. Binds aromatase, reducing oestrogen conversion from concurrent compounds.
• Reduces water retention and sharpens vascularity by the third week.
• Best at low body fat. The visual payoff scales with how lean you already are.

Intended for use under the supervision of a qualified medical professional and in jurisdictions where lawful.

Administration

Doses must be individualized under the supervision of a qualified clinician based on baseline bloodwork and ongoing monitoring.

Release Profile

• Half-life — approximately 2–3 days
• Onset — serum rises within 48 hours of first injection
• Visible cosmetic effect — typically apparent from week 3 if body fat is already low
• Clearance — drops within 5–7 days of last injection

Storage

• Store at 15–25 °C, away from direct sunlight
• Keep in the original carton until immediately before use
• Discard any vial with precipitation, discolouration, or a compromised cap seal

Contraindications & Cautions

• Not for use during pregnancy, lactation, or with known carcinoma of the breast or prostate
• Severe hepatic, renal, or cardiac impairment
• Hypersensitivity to the active or oil carrier
• Can accelerate androgenic side effects (hair loss, skin) in predisposed users

Regular bloodwork is advised. Discontinue and seek medical advice if abnormal lab values appear.

Why Injectable Stanozolol

• Drops SHBG. Frees up bound testosterone and other ester compounds in your stack — making them functionally stronger.
• Dry, hard look. Zero aromatisation and very low water retention.
• Raw strength. Significant strength gains without bodyweight increase — ideal for weight‑class athletes.
• Lower hepatic load than oral. IM administration bypasses first‑pass metabolism.

Intended for use under the supervision of a qualified medical professional and in jurisdictions where lawful.

Administration

Doses must be individualized under the supervision of a qualified clinician based on baseline bloodwork and ongoing monitoring.

Release Profile

• Half-life — approximately 24 hours
• Onset — within hours of injection
• Stable serum — requires frequent dosing (EOD minimum) to maintain
• Clearance — out of system within days of last injection

Storage

• Store at 15–25 °C, away from direct sunlight
• Shake well before each draw — stanozolol settles to the bottom of suspension
• Keep in the original carton until use
• Discard any vial with abnormal colour or compromised cap seal

Contraindications & Cautions

• Not for use during pregnancy, lactation, or with known carcinoma of the breast or prostate
• Severe hepatic, renal, or cardiac impairment
• Lipid impact: stanozolol crashes HDL aggressively — bloodwork before, during, and after is essential
• Joint dryness is common — reduce or discontinue if joint pain develops

Regular bloodwork is advised, particularly a full lipid panel. Discontinue and seek medical advice if abnormal lab values appear.

Why Trenbolone

• The strongest commonly‑used anabolic. Receptor binding several times that of testosterone.
• Dramatic recomposition. Lean tissue gain and fat loss happen simultaneously in a way few compounds replicate.
• No aromatisation. Zero estrogen conversion — dry, hard physique.
• Fast exit. Short ester lets you stop quickly if side effects become difficult.

Significant side‑effect profile. Intended for experienced users with active bloodwork support, under the supervision of a qualified medical professional and in jurisdictions where lawful.

Administration

Not a beginner compound. Doses must be individualized under the supervision of a qualified clinician with active bloodwork monitoring.

Release Profile

• Half-life — approximately 2 days
• Onset — serum and strength noticeable within 24–48 hours
• Stable serum — requires EOD dosing to maintain
• Clearance — out within 5–7 days of last injection

Storage

• Store at 15–25 °C, away from direct sunlight
• Keep in the original carton until immediately before use
• Discard any vial with precipitation, discolouration, or a compromised cap seal

Important Cautions

• Cardiovascular impact. Trenbolone significantly affects blood pressure and cardiac stress. Monitor BP throughout.
• Sleep and mood. Severe insomnia, night sweats, and irritability are common. If quality of life crashes, stop.
• Renal stress. Trenbolone discolours urine and increases renal load — hydrate aggressively, monitor kidney markers.
• Not for first‑time users. Without prior cycle experience, you will not know what is trenbolone and what is something else going wrong.

Active bloodwork is mandatory: lipid panel, CBC, renal panel, blood pressure log. Discontinue immediately if severe sides develop. There is no compound on this site that should be respected more.

Why Boldenone

• Lean tissue gains without the water retention of testosterone or nandrolone.
• Raised red blood cell count. Improved endurance, vascularity, and recovery.
• Low estrogenic conversion. About half the aromatisation rate of testosterone.
• Mild on the HPTA compared to nandrolone — recovery after cycle is more manageable.

Intended for use under the supervision of a qualified medical professional and in jurisdictions where lawful.

Administration

Doses must be individualized under the supervision of a qualified clinician based on baseline bloodwork and ongoing monitoring.

Release Profile

Undecylenate is one of the longest esters in common use:

• Half-life — approximately 14 days
• Onset — noticeable effects take 2–3 weeks to develop
• Plateau — full activity at week 4–6 of consistent dosing
• Clearance — serum stays elevated for 4–6 weeks after the last injection

Storage

• Store at 15–25 °C, away from direct sunlight
• Keep in the original carton until immediately before use
• Do not refrigerate — the oil suspension thickens at low temperatures
• Discard any vial with precipitation, discolouration, or a compromised cap seal

Contraindications & Cautions

• Not for use during pregnancy, lactation, or with known carcinoma of the breast or prostate
• Severe hepatic, renal, or cardiac impairment
• Hypersensitivity to the active or oil carrier
• Raised hematocrit is common with long‑term use — monitor and consider periodic donation

Regular bloodwork is advised (CBC including hematocrit, lipid panel, hormone panel). Discontinue and seek medical advice if abnormal lab values appear.